Nieuws !!
Insmed Incorporated and Transave, Inc. Announce Business Combination
INSMED INCORPORATED AND TRANSAVE, INC. COMBINE TO CREATE A BIOPHARMACEUTICAL COMPANY WITH NEAR-TERM COMMERCIAL OPPORTUNITIES
COMPANY TO HOST CONFERENCE CALL AT 8:30 AM ET TODAY
RICHMOND, Va., Dec. 2, 2010 /PRNewswire-FirstCall/ -- Insmed Incorporated (Nasdaq CM: INSM), a biopharmaceutical company, announced today that it has entered into a business combination, effective immediately, with Transave, Inc., a privately-held, NJ-based biopharmaceutical company focused on the development of differentiated, innovative inhaled pharmaceuticals for the site-specific treatment of serious lung infections.